We are live on ! Find out more
PTC

Private Trust Company Portfolio holdings

AUM $1.25B
1-Year Est. Return 29.12%
This Fund
S&P 500
This Quarter Est. Return
+2.73%
1 Year Est. Return
+29.12%
3 Year Est. Return
+79.64%
5 Year Est. Return
+96.77%
10 Year Est. Return
+318.79%
AUM
$459M
AUM Growth
+$25.9M
Cap. Flow
+$15.6M
Cap. Flow %
3.4%
Top 10 Hldgs %
21.31%
Holding
383
New
31
Increased
163
Reduced
123
Closed
19

Top Sells

Rank Stock Value
1
UI icon
Ubiquiti
UI
+$1.22M
2
ETP
Energy Transfer Partners L.p.
ETP
+$805K
3
O icon
Realty Income
O
+$759K
4
MAT icon
Mattel
MAT
+$656K
5
BCR
CR Bard Inc.
BCR
+$589K

Sector Composition

Rank Sector Weight
1 Healthcare 13.97%
2 Industrials 12.6%
3 Consumer Staples 11.97%
4 Technology 9.16%
5 Financials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGG icon
76
iShares Core US Aggregate Bond ETF
AGG
$139B
$1.55M 0.34%
14,172
-1,051
-7% -$115K
UNH icon
77
UnitedHealth
UNH
$361B
$1.51M 0.33%
8,150
+748
+10% +$131K
PNC icon
78
PNC Financial Services
PNC
$97.9B
$1.44M 0.31%
11,517
+62
+0.5% +$7.48K
LKQ icon
79
LKQ Corp
LKQ
$6.51B
$1.43M 0.31%
43,523
-1,635
-4% -$50.5K
VWO icon
80
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$1.37M 0.3%
33,543
+19,915
+146% +$807K
MDLZ icon
81
Mondelez International
MDLZ
$80.9B
$1.36M 0.3%
31,584
+1,198
+4% +$54K
TJX icon
82
TJX Companies
TJX
$152B
$1.34M 0.29%
37,138
-154
-0.4% -$5.81K
MMP
83
DELISTED
Magellan Midstream Partners, L.P.
MMP
$1.34M 0.29%
18,792
+1,009
+6% +$74.1K
BSX icon
84
Boston Scientific
BSX
$70.1B
$1.33M 0.29%
47,878
-3
-0% -$80
IEMG icon
85
iShares Core MSCI Emerging Markets ETF
IEMG
$161B
$1.29M 0.28%
25,854
+12,462
+93% +$615K
GD icon
86
General Dynamics
GD
$103B
$1.29M 0.28%
6,497
-1,127
-15% -$221K
WBA
87
DELISTED
Walgreens Boots Alliance
WBA
$1.28M 0.28%
16,397
-551
-3% -$45.3K
LMT icon
88
Lockheed Martin
LMT
$131B
$1.28M 0.28%
4,606
+126
+3% +$34.6K
COO icon
89
Cooper Companies
COO
$14.2B
$1.26M 0.27%
21,056
-628
-3% -$34.1K
KMI icon
90
Kinder Morgan
KMI
$71.3B
$1.24M 0.27%
64,889
-7,663
-11% -$152K
AMGN icon
91
Amgen
AMGN
$238B
$1.24M 0.27%
7,178
+86
+1% +$14K
CSX icon
92
CSX Corp
CSX
$96.3B
$1.23M 0.27%
67,803
+27
+0% +$463
WMT icon
93
Walmart Inc
WMT
$834B
$1.23M 0.27%
48,654
-6,351
-12% -$161K
ADI icon
94
Analog Devices
ADI
$180B
$1.22M 0.27%
15,669
+5,523
+54% +$439K
NGG icon
95
National Grid
NGG
$80.9B
$1.22M 0.27%
21,911
-20
-0.1% -$1.22K
CAG icon
96
Conagra Brands
CAG
$7.79B
$1.2M 0.26%
33,445
-6,440
-16% -$249K
RTN
97
DELISTED
Raytheon Company
RTN
$1.12M 0.24%
6,953
+140
+2% +$22.2K
CAH icon
98
Cardinal Health
CAH
$55.4B
$1.11M 0.24%
14,259
+528
+4% +$39.8K
BF.A icon
99
Brown-Forman Class A
BF.A
$13.2B
$1.11M 0.24%
28,125
IEFA icon
100
iShares Core MSCI EAFE ETF
IEFA
$196B
$1.1M 0.24%
18,045
+5,303
+42% +$320K

Similar funds

Private Trust Company's Q2 2017 Portfolio in Review

As of Q2 2017, Private Trust Company held 383 positions worth $459M, up 6% from $433M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Private Trust Company deployed $15.6M of net new capital in Q2 2017, opening 31 new positions and adding to 163 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 7,862 shares worth $956K.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was Realty Income, an estimated $759K trimmed.

  • Private Trust Company's largest Q2 2017 buy was Alexion Pharmaceuticals: 7,862 shares worth $956K.
  • Private Trust Company added most to iShares Core S&P Mid-Cap ETF in Q2 2017, an estimated $1.23M increase.
  • Private Trust Company's biggest Q2 2017 reduction was Realty Income, cutting an estimated $759K.
  • Private Trust Company fully exited Ubiquiti in Q2 2017, selling an estimated $1.22M.
  • Private Trust Company's ten largest holdings make up 21% of its $459M portfolio in Q2 2017.
  • Private Trust Company opened 31 new positions and closed 19 in Q2 2017.
  • Private Trust Company's portfolio value rose 6% quarter-over-quarter to $459M.

Based on Private Trust Company's 13F filing for Q2 2017, filed 11 Jul 2017.